Related Experiment Videos
Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet
1Department of Clinical Haematology, St. George Hospital, Sydney, Australia.
European Journal of Haematology
|March 1, 1988
Summary
Platelet function abnormalities in myeloproliferative disorders (MPD) are complex, with both hyper- and hypofunction observed. Repeated testing is crucial for accurate bleeding and thrombosis risk assessment in MPD patients.
Area of Science:
- Hematology
- Oncology
- Thrombosis and Hemostasis
Background:
- Myeloproliferative disorders (MPD) are associated with significant bleeding and thrombosis risks.
- Platelet function abnormalities are common in MPD but their relationship with clinical outcomes is not fully established.
Purpose of the Study:
- To investigate platelet aggregation and cyclooxygenase activity in MPD patients.
- To determine the correlation between platelet function and clinical bleeding/thrombosis events.
- To assess the stability of platelet function over time in MPD.
Main Methods:
- Simultaneous laboratory evaluations of platelet aggregation and cyclooxygenase activity (using aspirin inhibition test) in 54 MPD patients.
- Repeat testing in 22 patients after 1-27 months to evaluate changes over time.
Main Results:
- Co-existence of platelet hyper- and hypofunction in 9 out of 54 patients.
- Changes in platelet function observed in 7 out of 22 patients during the disease course.
- Platelet hypofunction was the only consistent abnormality over time.
Conclusions:
- The dynamic nature of platelet function abnormalities may explain the lack of correlation in previous studies.
- Repeated platelet function evaluations are necessary for accurate risk assessment of bleeding and thrombosis in MPD.
- Understanding these fluctuations is key to managing MPD complications.